Navigation Links
The Attorneys of The Onder Law Firm Offers Free XOLAIR Case Review
Date:11/22/2009

The Onder Law Firm’s attorneys are offering a free XOLAIR case review to those or families of those who may have experienced heart attack, stroke or other serious health problems after taking XOLAIR.

St. Louis, MO (Vocus) November 22, 2009 -- The Onder Law Firm are among attorneys offering free XOLAIR case review for serious health problems such as heart attack and stroke. The attorneys of the Onder Law Firm include experienced pharmaceutical litigation attorneys. The Onder Law Firm, which handles cases on a national basis, is quickly becoming a leader in large and complex litigation. A partner in the firm was recently appointed as co-lead counsel in the Yaz lawsuit filed in U.S. District Court for the Southern District of Illinois (MDL No. 2100).

The FDA is currently evaluating interim safety findings in an ongoing study of XOLAIR problems. XOLAIR (omalizumab) is an injected drug for asthma related allergies. The interim results of this study, which is being conducted by the drug’s manufacturer, Genentech, Inc., suggests an increased number of cardiovascular (heart attack) and cerebrovascular (stroke) adverse events in a group of patients using Xolair compared to a group of patients not given the drug (control group). The possible association has been identified based on interim results from an ongoing study of Xolair known as Evaluating the Clinical Effectiveness and Long-Term Safety in Patients with Moderate to Severe Asthma (EXCELS). The results this study are not expected until 2012. Although the FDA and the drug manufacturer have not recalled XOLAIR, the FDA wants consumers to be aware of increased risks from taking XOLAIR, specifically heart attack/heart disease and stroke.

The Onder Law Firm, attorneys for XOLAIR cases, have launched a site that contains information regarding XOLAIR side effects and the rights those suffering from them may have. The attorneys of The Onder Law Firm will review will provide free XOLAIR case review to persons having experienced side effects or medical problems after taking the drug. The Onder Law Firm provides experienced legal representation without fee unless it collects for its clients.

About The Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O’Leary & Peterson has represented clients throughout the United States in pharmaceutical litigation such as Vioxx, Digitek, Ethex and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit www.onderlaw.com or call 1-877-ONDER-LAW.

# # #

Read the full story at http://www.prweb.com/releases/xolair/lawyers/prweb3244494.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Verdict One Releases Directory of Board Certified Attorneys for Consumers
2. Former Pfizer Patent Attorneys Join Brinks Hofer Gilson & Lione
3. Statement from AAJ President Kathleen Flynn Peterson on ATRAs Latest Attack on Civil Justice Attorneys
4. Leventhal Weight Loss Incorporated Becomes First in the Nation Executive Weight Loss Consulting Service for Attorneys by an Attorney
5. Social Security Attorneys Prepare for Increased Baby Boomer SSI Claims
6. Hagens Berman Sobol Shapiro: Attorneys Representing Consumers Prepare for $12 Billion RICO Trial Against McKesson for Alleged Drug Price Manipulation
7. Social Security Attorneys Focus on Localized SEO Friendly Content
8. SumoBrain Adds Bulk PDF Downloading : Free Service Saves Money and Time for Attorneys, Inventors and Corporate IP Professionals
9. Cleveland Injury Attorneys Among 'The Best Lawyers in America'
10. Five Lubin & Meyer Lawyers Named Top Medical Malpractice Attorneys: Selected as Super Lawyers 2008
11. Jones Walker Attorneys Named to Positions in Order of British Crown
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The Attorneys of The Onder Law Firm Offers Free XOLAIR Case Review
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology: